Co-Authors
This is a "connection" page, showing publications co-authored by Paolo Pelosi and Pedro Silva.
Connection Strength
0.512
-
The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19. Pharmacol Res Perspect. 2020 08; 8(4):e00623.
Score: 0.224
-
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trial. Eur Respir J. 2021 07; 58(1).
Score: 0.060
-
Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review. Br J Anaesth. 2021 09; 127(3):353-364.
Score: 0.059
-
Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front Physiol. 2021; 12:593223.
Score: 0.058
-
Pros and cons of corticosteroid therapy for COVID-19 patients. Respir Physiol Neurobiol. 2020 09; 280:103492.
Score: 0.056
-
Emerging therapies for COVID-19 pneumonia. Expert Opin Investig Drugs. 2020 Jul; 29(7):633-637.
Score: 0.055